Inaktiver Wert

Celator Pharmaceuticals Inc Aktie

Aktien

Schlusskurs Nasdaq Andere Börsenplätze
- ^USD	-

Brower Piven Commences An Investigation Into The Proposed Sale Of Celator Pharmaceuticals, Inc. And Encourages Shareholders To Contact The Firm For Additional Information	14.06.16
CELATOR PHARMACEUTICALS, INC. Former SEC Attorney Willie Briscoe and Powers Taylor LLP Investigate Sale to Jazz Pharmaceuticals plc	02.06.16
Celator Pharmaceuticals : Jazz Pharma to buy Celator in $1.5 billion deal	31.05.16
Celator Pharmaceuticals : Jazz Pharma nears deal to buy Celator for about $1.5 billion - WSJ	31.05.16
Steve Cohen’s Point72 says it has perfect U.S. compliance	18.03.16

Manager	Titel	Alter	Seit
Arthur C. Louie CTO	Chief Tech/Sci/R&D Officer	-	-

Sektor

	% 1. Jan.	Kap.
MODERNA, INC.	+25,69 %	47,86 Mrd.
LONZA GROUP AG	+46,90 %	41,42 Mrd.
IQVIA HOLDINGS INC.	-3,46 %	40,66 Mrd.
CELLTRION, INC.	-6,20 %	28,92 Mrd.
ICON PUBLIC LIMITED COMPANY	+9,17 %	25,55 Mrd.
ALNYLAM PHARMACEUTICALS, INC.	-20,42 %	19,27 Mrd.
MEDPACE HOLDINGS, INC.	+28,07 %	12,14 Mrd.
BIO-TECHNE CORPORATION	+0,17 %	12,15 Mrd.
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.	-1,24 %	11,99 Mrd.